| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accurate, rapid, point-of-care tests for sexually transmitted infections
|
Unemo, Magnus
|
|
|
21 |
5 |
p. 584-586
|
article
|
| 2 |
A legacy of disease
|
Gröschel, Matthias I
|
|
|
21 |
5 |
p. 614
|
article
|
| 3 |
Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19
|
Nicolás, David
|
|
|
21 |
5 |
p. 591-593
|
article
|
| 4 |
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial
|
Van Dijck, Christophe
|
|
|
21 |
5 |
p. 657-667
|
article
|
| 5 |
Antibiotic overuse in China: call for consolidated efforts to develop antibiotic stewardship programmes
|
Walley, John D
|
|
|
21 |
5 |
p. 597
|
article
|
| 6 |
Antiseptic mouthwashes against sexually transmitted infections
|
de Vries, Henry J C
|
|
|
21 |
5 |
p. 583-584
|
article
|
| 7 |
Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial
|
Chow, Eric P F
|
|
|
21 |
5 |
p. 647-656
|
article
|
| 8 |
Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses
|
Zaid, Ali
|
|
|
21 |
5 |
p. e123-e133
|
article
|
| 9 |
Associations between phone mobility data and COVID-19 cases
|
Gatalo, Oliver
|
|
|
21 |
5 |
p. e111
|
article
|
| 10 |
A year and a day of #Covid19uk tweets
|
Mackenzie, Graham
|
|
|
21 |
5 |
p. 616
|
article
|
| 11 |
Beyond COVID-19—a paradigm shift in infection management?
|
Vehreschild, Maria J G T
|
|
|
21 |
5 |
p. e117
|
article
|
| 12 |
Bilateral infiltrates in a health-care worker during the COVID-19 pandemic
|
Schindler, Otmar
|
|
|
21 |
5 |
p. 742
|
article
|
| 13 |
CEPI prepares for future pandemics and epidemics
|
Samarasekera, Udani
|
|
|
21 |
5 |
p. 608
|
article
|
| 14 |
Change in obstetric attendance and activities during the COVID-19 pandemic
|
Khalil, Asma
|
|
|
21 |
5 |
p. e115
|
article
|
| 15 |
Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study
|
Bennett, Aisleen
|
|
|
21 |
5 |
p. 731-740
|
article
|
| 16 |
Congenital malformations in sub-Saharan Africa—warnings of a silent epidemic?
|
Sié, Ali
|
|
|
21 |
5 |
p. 594-596
|
article
|
| 17 |
Correction to Lancet Infect Dis 2021; 21: 697–710
|
|
|
|
21 |
5 |
p. e122
|
article
|
| 18 |
Correction to Lancet Infect Dis 2021; 21: 677–87
|
|
|
|
21 |
5 |
p. e122
|
article
|
| 19 |
Correction to Lancet Infect Dis 2021; published online Jan 29. https://doi.org/10.1016/S1473-3099(20)30692-7
|
|
|
|
21 |
5 |
p. e122
|
article
|
| 20 |
Correction to Lancet Infect Dis 2020; published online March 25. https://doi.org/10.1016/S1473-3099(21)00151-1
|
|
|
|
21 |
5 |
p. e122
|
article
|
| 21 |
COVID-19: the deadly threat of misinformation
|
Galvão, Jane
|
|
|
21 |
5 |
p. e114
|
article
|
| 22 |
CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants
|
Alam, Intikhab
|
|
|
21 |
5 |
p. 602
|
article
|
| 23 |
CROI 2021
|
Kazi, Farooq
|
|
|
21 |
5 |
p. 606
|
article
|
| 24 |
Defining the diagnosis of cryptosporidiosis
|
Chalmers, Rachel M
|
|
|
21 |
5 |
p. 589-590
|
article
|
| 25 |
Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab
|
Niitsuma-Sugaya, Ikumi
|
|
|
21 |
5 |
p. 741
|
article
|
| 26 |
Dog's own country
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
5 |
p. 615
|
article
|
| 27 |
Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study
|
Babiker, Ahmed
|
|
|
21 |
5 |
p. 697-710
|
article
|
| 28 |
Effectiveness of rotavirus vaccine in preventing transmission of rotavirus from children to household contacts in Malawi
|
Mwenyenkulu, Tisungane Edward
|
|
|
21 |
5 |
p. 590-591
|
article
|
| 29 |
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
|
Nazemipour, Maryam
|
|
|
21 |
5 |
p. 603-604
|
article
|
| 30 |
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
|
Ghafari, Mahan
|
|
|
21 |
5 |
p. 602-603
|
article
|
| 31 |
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
|
Darvishian, Maryam
|
|
|
21 |
5 |
p. 604-605
|
article
|
| 32 |
Faecal microbiota transplantation: more screening for old and new pathogens
|
Hohmann, Elizabeth L
|
|
|
21 |
5 |
p. 587-589
|
article
|
| 33 |
First immunogenicity data for the UK serogroup B meningococcal vaccination schedule in infants
|
McNamara, Lucy A
|
|
|
21 |
5 |
p. 586-587
|
article
|
| 34 |
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study
|
Li, Fang
|
|
|
21 |
5 |
p. 617-628
|
article
|
| 35 |
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism
|
Peiffer-Smadja, Nathan
|
|
|
21 |
5 |
p. e121
|
article
|
| 36 |
Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
|
Van Elslande, Jan
|
|
|
21 |
5 |
p. e120
|
article
|
| 37 |
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
|
Davis, Kimberly
|
|
|
21 |
5 |
p. 688-696
|
article
|
| 38 |
“In an ocean of ashes, islands of order”: WHO's SARS-CoV-2 origin report
|
The Lancet Infectious Diseases,
|
|
|
21 |
5 |
p. 579
|
article
|
| 39 |
Infectious diseases in Yemen
|
Burki, Talha
|
|
|
21 |
5 |
p. 610-611
|
article
|
| 40 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
21 |
5 |
p. 611
|
article
|
| 41 |
Intention to vaccinate against COVID-19 in Australia
|
Rhodes, Anthea
|
|
|
21 |
5 |
p. e110
|
article
|
| 42 |
Journey to Wuhan during its lockdown
|
Burki, Talha
|
|
|
21 |
5 |
p. 613
|
article
|
| 43 |
Limitations of using mobile phone data to model COVID-19 transmission in the USA
|
Badr, Hamada S
|
|
|
21 |
5 |
p. e113
|
article
|
| 44 |
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
|
Norton, Alice
|
|
|
21 |
5 |
p. 601-602
|
article
|
| 45 |
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions
|
Mondelli, Mario U
|
|
|
21 |
5 |
p. e112
|
article
|
| 46 |
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results
|
MacLennan, Jenny M
|
|
|
21 |
5 |
p. 677-687
|
article
|
| 47 |
MIS-C: post-infectious syndrome or persistent infection?
|
Schwartz, Michael
|
|
|
21 |
5 |
p. e116
|
article
|
| 48 |
Optimism and caution for an inactivated COVID-19 vaccine
|
Rostad, Christina A
|
|
|
21 |
5 |
p. 581-582
|
article
|
| 49 |
Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study
|
Johansen, Øystein H
|
|
|
21 |
5 |
p. 722-730
|
article
|
| 50 |
Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study
|
Morris, Sheldon R
|
|
|
21 |
5 |
p. 668-676
|
article
|
| 51 |
Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study
|
Vendrik, Karuna E W
|
|
|
21 |
5 |
p. 711-721
|
article
|
| 52 |
Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
|
Mohapatra, Prasanta Raghab
|
|
|
21 |
5 |
p. 599-600
|
article
|
| 53 |
Research in brief
|
Devi, Sharmila
|
|
|
21 |
5 |
p. 612
|
article
|
| 54 |
Rotavirus vaccine for children facing humanitarian crisis
|
Bagcchi, Sanjeet
|
|
|
21 |
5 |
p. 609
|
article
|
| 55 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
|
Ella, Raches
|
|
|
21 |
5 |
p. 637-646
|
article
|
| 56 |
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
|
Stringhini, Silvia
|
|
|
21 |
5 |
p. 600-601
|
article
|
| 57 |
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
|
Choy, Kay Weng
|
|
|
21 |
5 |
p. e118
|
article
|
| 58 |
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
|
Iversen, Kasper
|
|
|
21 |
5 |
p. e119
|
article
|
| 59 |
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
|
Pallett, Scott J C
|
|
|
21 |
5 |
p. 598-599
|
article
|
| 60 |
1st Women in Malaria conference
|
Barksby, Rebecca
|
|
|
21 |
5 |
p. 607
|
article
|
| 61 |
Technical assessment of the neonatal early-onset sepsis risk calculator
|
Benitz, William E
|
|
|
21 |
5 |
p. e134-e140
|
article
|
| 62 |
The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada
|
Maharaj, Arjuna S
|
|
|
21 |
5 |
p. 593-594
|
article
|
| 63 |
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
|
Marks, Michael
|
|
|
21 |
5 |
p. 629-636
|
article
|
| 64 |
Understanding the drivers of transmission of SARS-CoV-2
|
Cornelissen, Laura
|
|
|
21 |
5 |
p. 580-581
|
article
|
| 65 |
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens
|
Choby, Jacob E
|
|
|
21 |
5 |
p. 597-598
|
article
|
Journal description